Jian Zhang starts the presentation with prevalence data in China and the recommendation from Chinese Guidelines. Key messages of the presentation include:

• The unmet medical needs in patients with heart failure in China:
  • Low prescription rates of guideline recommended medications
  • Suboptimal heart rate control
• Data from China:
  • SHIFT Chinese subgroup analysis
  • POSITIVE study
  • Other explorations (the combination of ivabradine in vulnerable and predischarge stages)
• The Chinese expert consensus recommends ivabradine in heart failure and other diseases:
  • Early combination in patients with chronic HFrFE
  • In vulnerable phase of heart failure
    • AHF entered into pre-discharge stage
• Patients not tolerating or with contraindications to beta-blockers
  • Coronary heart disease